These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2646862)

  • 61. Two neutralizing human anti-RSV antibodies: cloning, expression, and characterization.
    Heard C; Brams P; Walsh E; Huynh T; Chamat S; Reff M; Owyang A; Shestowsky W; Newman R
    Mol Med; 1999 Jan; 5(1):35-45. PubMed ID: 10072446
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Antibody engineering and gene therapy in cancer].
    Hinoda Y; Imai K
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Oct; 19(5):453-9. PubMed ID: 8983663
    [No Abstract]   [Full Text] [Related]  

  • 63. Expression of a biologically active antiviral antibody using a sindbis virus vector system.
    Liang XH; Jiang HH; Levine B
    Mol Immunol; 1997; 34(12-13):907-17. PubMed ID: 9464526
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tools for coproducing multiple proteins in mammalian cells.
    Assur Z; Hendrickson WA; Mancia F
    Methods Mol Biol; 2012; 801():173-87. PubMed ID: 21987254
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Engineering antibodies for therapy.
    Adair JR
    Immunol Rev; 1992 Dec; 130():5-40. PubMed ID: 1286872
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Principles and applications of recombinant antibody phage display technology to plant biology.
    Crosby WL; Schorr P
    Methods Cell Biol; 1995; 50():85-99. PubMed ID: 8531823
    [No Abstract]   [Full Text] [Related]  

  • 67. Novel diagnostic and therapeutic strategies with genetically engineered human antibodies.
    Ouwehand WH; Watkins N
    Vox Sang; 1998; 74 Suppl 2():223-32. PubMed ID: 9704449
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Recombinant design and expression of human anti-rabies virus ScdsFv].
    Cai K; Wang H; Bao SZ; Shi J; Hou XJ
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):673-6. PubMed ID: 17944370
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Entamoeba histolytica: bacterial expression of a human monoclonal antibody which inhibits in vitro adherence of trophozoites.
    Cheng XJ; Ihara S; Takekoshi M; Tachibana H
    Exp Parasitol; 2000 Sep; 96(1):52-6. PubMed ID: 11038321
    [No Abstract]   [Full Text] [Related]  

  • 70. Tailor-made monoclonal antibodies.
    DePinho RA; Feldman LB; Scharff MD
    Ann Intern Med; 1986 Feb; 104(2):225-33. PubMed ID: 3080934
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Homology of an antiacetylcholine receptor monoclonal antibody with a monoclonal antibody to Campath-1 antigen suggests usage of the same VH genes.
    Agius MA; Kirvan CA; Sanyal B
    Ann N Y Acad Sci; 1998 May; 841():469-70. PubMed ID: 9668276
    [No Abstract]   [Full Text] [Related]  

  • 72. Engineering the quaternary structure of an exported protein with a leucine zipper.
    Blondel A; Bedouelle H
    Protein Eng; 1991 Apr; 4(4):457-61. PubMed ID: 1881871
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Designing and optimizing library selection strategies for generating high-affinity antibodies.
    Hoogenboom HR
    Trends Biotechnol; 1997 Feb; 15(2):62-70. PubMed ID: 9081300
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Production of a diverse repertoire of human antibodies in genetically engineered mice.
    Ishida I; Yoshida H; Tomizuka K
    Microbiol Immunol; 1998; 42(3):143-50. PubMed ID: 9570278
    [No Abstract]   [Full Text] [Related]  

  • 75. Saccharomyces cerevisiae Shuttle vectors.
    Gnügge R; Rudolf F
    Yeast; 2017 May; 34(5):205-221. PubMed ID: 28072905
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The prospects for recombinant proteins from transgenic animals: A few successes along with the advent of new technologies increase the allure of transgenic animals for the production of therapeutic human proteins.
    Hunter P
    EMBO Rep; 2019 Aug; 20(8):e48757. PubMed ID: 31304991
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Obtaining of ScFv-CBD fusion protein and its application for affinity purification of recombinant human interferon alpha2b].
    Hil'chuk PV; Okuniev OV; Pavlova MV; Irodov DM; Horbatiuk OB
    Ukr Biokhim Zh (1999); 2006; 78(2):52-61. PubMed ID: 17100285
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of a functional monoclonal single-chain variable fragment antibody against Venezuelan equine encephalitis virus.
    Alvi AZ; Stadnyk LL; Nagata LP; Fulton RE; Bader DE; Roehrig JT; Suresh MR
    Hybridoma; 1999 Oct; 18(5):413-21. PubMed ID: 10600028
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Parallel selection of antibody libraries on phage and yeast surfaces via a cross-species display.
    Patel CA; Wang J; Wang X; Dong F; Zhong P; Luo PP; Wang KC
    Protein Eng Des Sel; 2011 Sep; 24(9):711-9. PubMed ID: 21750005
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Biotechnological production of growth hormone].
    Rossi F; Mangrella M
    Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):21-9. PubMed ID: 8190044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.